arrow_back Trending Legislation
Share share

Oral Drugs Exempted from Medicare Part D Discount Program

This bill aims to exempt certain orally administered drugs from the Medicare Part D manufacturer discount program. This means manufacturers of these specific drugs will not be required to offer discounts, potentially affecting their availability and prices for Medicare beneficiaries.
Key points
The bill exempts orally administered drugs approved by the FDA and granted a narrow reclassification exception under Medicaid from Medicare Part D discounts.
This change could impact the costs and accessibility of certain medications for seniors and individuals with disabilities covered by Medicare.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Ensuring Access to Essential Drugs Act
Print number: HR 1922
Sponsor: Rep. Garbarino, Andrew R. [R-NY-2]
Process start date: 2025-03-06